Article Details
Retrieved on: 2025-03-15 15:08:13
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Wedbush cut their target price on shares of Vigil Neuroscience from $24.00 to $13.00 and set an "outperform" rating on the stock in a report on ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here